EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-29a as a molecular target in cancer: Prevention strategies with natural products

Muhanad Alhujaily

Current Molecular Pharmacology · 2026 · 19 (1) · 48-60

DOI: 10.1016/j.cmp.2026.03.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Muhanad Alhujaily. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imam Mohammed Ibn Saud Islamic University, Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is one of the foremost causes of mortality worldwide and is characterized by uninterrupted cell growth, metastasis, and resistance to therapy. The present approach in molecular biology has emphasised the pivotal role of microRNAs (miRNAs) in regulating various cancer hallmarks. Among these, miR-29a has emerged as a pivotal regulator in the advancement of cancer, exhibiting as either an oncogene or a tumour suppressor depending on the cellular context. miRNA synthesis is biphasic – firstly, primary miRNA forms in the nucleus, then it is processed by Drosha (nucleus) and Dicer (cytoplasm) into mature miRNA. The miR-29 family (miR-29a, miR-29b, miR-29c) is linked to tumour aggressiveness and patient prognosis, making it a potential biomarker for predicting cancer development and recurrence. MiR-29a influences the tumour microenvironment and prevents invasion by selectively targeting collagen substrates. Research studies have demonstrated the impact of natural bioactive compounds in modulating the expression of miR-29a, which is known for its tumour-suppressive functions. Several natural products, including polyphenols, flavonoids, alkaloids, and terpenoids, have shown promising results in preclinical investigations by targeting key signalling pathways regulated by miR-29a. Further studies are imperative to elucidate the precise mechanisms through which miRNA-29a interacts with natural bioactive compounds in order to facilitate the development of novel therapeutic strategies in cancer treatment. This review comprehensively explores how natural bioactive compounds regulate miR-29a expression and their potential implication in cancer prevention, emphasising the integration of traditional knowledge with modern therapeutic approaches.

Förderung

  • Imam Mohammed Ibn Saud Islamic University
  • Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research

Zitieren

APA

Alhujaily, M. (2026). MiR-29a as a molecular target in cancer: Prevention strategies with natural products. Current Molecular Pharmacology, 19(1), 48-60. https://doi.org/10.1016/j.cmp.2026.03.003

Vancouver

Alhujaily M. MiR-29a as a molecular target in cancer: Prevention strategies with natural products. Current Molecular Pharmacology. 2026;19(1):48-60. doi:10.1016/j.cmp.2026.03.003

BibTeX
@article{Alhujaily2026,
  author = {Alhujaily, Muhanad},
  title = {MiR-29a as a molecular target in cancer: Prevention strategies with natural products},
  journal = {Current Molecular Pharmacology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {48--60},
  doi = {10.1016/j.cmp.2026.03.003}
}
Kostenlos starten →